1959572-97-4: Axitinib Impurity C
It is an impurity of Axitinib, it is a potent and selective second-generation inhibitor of vascular endothelial growth factor receptors that are used in first-line treatment of metastatic renal cell carcinoma
Additional information on CAS 1959572-97-4
Axitinib Impurity C
Bellesoeur, Audrey, et al. “Axitinib in the Treatment of Renal Cell Carcinoma: Design, Development, and Place in Therapy.” Drug Design, Development and Therapy, vol. Volume 11, Sept. 2017, pp. 2801–2811, 10.2147/dddt.s109640. Accessed 1 Sept. 2019.
Other products related to axitinib
|CAS No.||Name of Impurity||Parent Drug||Catalogue No.|